Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
From a population health standpoint, the CDC estimates that more than 38 million Americans (11.6% of the population) have diabetes, and approximately 9095% of cases are Type 2
Ideal for AOD-9604 may fit you if: - You want fat-loss support without raising your growth hormone or IGF-1 - You prefer a gentler, non-hormonal approach and are comfortable with modest effects - Blood sugar and insulin sensitivity are concerns you want to leave undisturbed - You are interested in stacking with a metabolic peptide like MOTS-c for a cellular reset - You do not want to affect appetite or muscle mass Consider alternatives if Tesamorelin may fit you if: - Deep abdominal (visceral) fat is your main target - FDA approval and large clinical-trial evidence matter to you - You want the most clinically validated fat-loss peptide available - You are comfortable raising your own GH and IGF-1 as part of the approach - Liver fat or triglycerides are part of the picture your provider is watching The decision is not really AOD-9604 versus Tesamorelin as better or worse
they address different research questions about different aspects of GH biology
Research shows both peptides are well tolerated, with very low rates of adverse events
